Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Prostate Cancer Clinical Trials

SCORE (30824)
SCORE -- Assessment of Mood, Information Processing and Quality of Life in Prostate Cancer Survivors and Patients
Status Conditions Phase Study ID
Closed Prostate Cancer NA 30824
Summary

The purpose of this study is to examine thinking abilities and emotions in survivors of prostate cancer.

We are seeking men for two separate parts of this study:

1) Control Group: Survivors of prostate cancer who are 6 months post primary treatment.

2) Treatment Group: Men with prostate cancer who are about to start hormone treatment with androgen deprivation therapy (ADT). Note: For the treatment group, participants must be enrolled in this study BEFORE starting ADT.

This is an outpatient study at the Seattle Cancer Care Alliance (SCCA) or Veterans Affairs Medical Center (VA) in Seattle. Participants will complete approximately 6 visits. Each visit will last about 2-3 hours and will include a blood draw.

Participants in the Treatment Group will receive either a testosterone gel or a placebo gel, to be used for one month following treatment with ADT. (The placebo gel is an inactive substance.) Participants will receive the gel and instructions in how to use it at the SCCA.

Compensation

1) Control Group (Survivors of prostate cancer who are 6 months post primary treatment): Compensation up to $150 upon completion of the study (check sent by mail).

2) Treatment Group (Men with prostate cancer who have not yet started treatment with androgen deprivation therapy [ADT]): Compensation up to $300 upon completion of the study (check sent by mail).


Investigator
Monique Cherrier, PhD
Location    
Seattle Cancer Care Alliance 800-804-8824  
Eligibility Criteria (must meet the following to participate in this study)

1) Control Group - Survivors of prostate cancer:

- More than 6 months have passed since last treatment for prostate cancer

- Not currently undergoing cancer treatment

2) Treatment Group - Men with prostate cancer who have not yet started treatment with androgen deprivation therapy (ADT):

- Must be eligible for ADT

- Must NOT have started ADT yet

All participants:

- Able to travel to the Seattle Cancer Care Alliance (SCCA) or Veterans Affairs Medical Center (VA) in Seattle - Committed to completing all visits

-Primary language is English

Other eligibility criteria may apply.

Exclusions (conditions that would prevent participation in this study)

- Currently undergoing androgen deprivation therapy (ADT) or other treatments such as chemo or radiotherapy

- Evidence of metastatic disease

- History of significant neurological disease such as Parkinson's, multiple sclerosis (MS), epilepsy/seizures, or major stroke

- History of head injury/trauma

- History of alcohol abuse, current alcohol abuse, or other substance abuse

- Major psychiatric illness such as schizophrenia or bipolar disorder

Other exclusion criteria may apply.

Last Updated
September 12, 2014
Access protocol and consent forms at Fred Hutchinson Cancer Research Center
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:
  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.